Osteopenia in children surviving brain tumours

被引:41
作者
Barr, RD
Simpson, T
Webber, CE
Gill, GJ
Hay, J
Eves, M
Whitton, AC
机构
[1] McMaster Univ, Childrens Hosp Chedoke McMaster, Hlth Sci Ctr, Hamilton, ON L8N 3Z5, Canada
[2] McMaster Univ, Fac Hlth Sci, Hamilton, ON L8N 3Z5, Canada
[3] Hamilton Reg Canc Ctr, Hamilton, ON L8V 1C3, Canada
[4] Brock Univ, St Catharines, ON L2S 3A1, Canada
关键词
osteopenia; children; brain tumours;
D O I
10.1016/S0959-8049(98)00011-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Osteopenia has been reported in children surviving acute lymphoblastic leukaemia, apparently as a consequence of therapy. It has been suggested that cranial irradiation may play a crucial role in this disorder. To explore that possibility, survivors of brain tumours in childhood, all of whom had received radiotherapy, were examined for evidence of bone mineral loss. 19 children were assessed, on average at 7 years after treatment. Measurements of growth velocities, plain radiography of the skeleton, bone densitometry, health-related quality of life and physical activity were undertaken. Growth hormone (GH) deficiency had been detected in 6 children and 5 had received GH replacement, for a minimum of more than 3 years. 9 children were radiographically osteopenic (including the 5 who had received GH). Z scores for bone mineral density (BMD) were negative in the majority of children. Health-related quality of life was less and pain more frequent in those with low BMD scores. Pain was correlated negatively with both free-time activity and seasonal activity (P<0.01). Osteopenia is a common sequel of therapy in children with brain tumours. Those with osteopenia have more pain and more compromised, health-related quality of life than those who are not osteopenic, and pain significantly limits physical activity. The pathogenesis of osteopenia in these children is still uncertain, but is Likely to be multifactorial. (C) 1998 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:873 / 877
页数:5
相关论文
共 33 条
  • [1] EFFECTS OF 1,25-DIHYDROXYVITAMIN-D(3) AND GROWTH-HORMONE THERAPY ON SERUM OSTEOCALCIN LEVELS IN CHILDREN WITH GROWTH-HORMONE DEFICIENCY
    ANTONIAZZI, F
    RADETTI, G
    ZAMBONI, G
    GAMBARO, G
    ADAMI, S
    TATO, L
    [J]. BONE AND MINERAL, 1993, 21 (02): : 151 - 156
  • [2] MINERAL HOMEOSTASIS AND BONE MASS IN CHILDREN TREATED FOR ACUTE LYMPHOBLASTIC-LEUKEMIA
    ATKINSON, SA
    FRAHER, L
    GUNDBERG, CM
    ANDREW, M
    PAI, M
    BARR, RD
    [J]. JOURNAL OF PEDIATRICS, 1989, 114 (05) : 793 - 800
  • [3] Barr RD, 1997, INT J ONCOL, V11, P333
  • [4] BARR RD, 1995, INT J PEDIAT HEM ONC, V2, P305
  • [5] BARR RD, 1993, MED PEDIATR ONCOL, V21, P537
  • [6] THE EFFECT OF GROWTH-HORMONE ADMINISTRATION IN GROWTH-HORMONE DEFICIENT ADULTS ON BONE, PROTEIN, CARBOHYDRATE AND LIPID HOMEOSTASIS, AS WELL AS ON BODY-COMPOSITION
    BINNERTS, A
    SWART, GR
    WILSON, JHP
    HOOGERBRUGGE, N
    POLS, HAP
    BIRKENHAGER, JC
    LAMBERTS, SWJ
    [J]. CLINICAL ENDOCRINOLOGY, 1992, 37 (01) : 79 - 87
  • [7] BLATT J, 1995, INT J PEDIAT HEM ONC, V2, P325
  • [8] BOOT AM, 1996, MED PEDIATR ONCOL, V27, P292
  • [9] BRENNAN BMD, 1996, MED PEDIATR ONCOL, V27, P347
  • [10] CALZOLARI A, 1985, J SPORT CARDIOL, V2, P108